Author:
Tomlin Andrew M.,Reith David M.,Woods David J.,Lloyd Hywel S.,Smith Alesha,Fountain John S.,Tilyard Murray W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference48 articles.
1. Torre C, Martins AP. Overview of pharmacoepidemiological databases in the assessment of medicines under real-life conditions. In: Lunet N, editor. Epidemiology—current perspectives on research and practice. Rijeka: InTech; 2012. p. 131–54.
2. Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153:600–6.
3. Huser V, DeFalco FJ, Schuemie M, et al. Multisite evaluation of a data quality tool for patient-level clinical datasets. eGEMs (Generating Evidence & Methods to improve patient outcomes). 2016;4(1):Article 24. doi:
10.13063/2327-9214.1239
.
https://egems.academyhealth.org/articles/abstract/10.13063/2327-9214.1239/
. Accessed 31 July 2017.
4. Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20:1–11.
5. García Rodríguez LA, Herings R, Johansson S. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins. Pharmacoepidemiol Drug Saf. 2010;19(12):1218–24.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献